Yokota Kenichi, Shibata Hirotaka, Kobayashi Sakiko, Suda Noriko, Murai Ayano, Kurihara Isao, Saito Ikuo, Saruta Takao
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Endocr Res. 2004 Nov;30(4):611-6. doi: 10.1081/erc-200043783.
The ubiquitin-proteasome pathway regulates the turnover of many nuclear hormone receptors, such as the estrogen receptor. For estrogen receptor, proteasome inhibition decreases ligand-mediated transcription. We provide evidence that the mineralocorticoid receptor (MR) is degraded by the ubiquitin-proteasome pathway in a ligand-dependent manner and that proteasomal inhibition results in increased accumulation of the MR with enhancement of transcriptional response to aldosterone. Examination of the primary sequence of human and rat MR has identified two candidate PEST degradation motifs. Mutation of lysine 715 and/or 367 within this PEST element failed to prevent degradation of MR protein or transcriptional activity mediated by aldosterone, indicating that other lysine residues are targeted by proteasomal degradation of MR. These findings demonstrate a coupling between MR up-regulation and transcriptional hyperactivity.
泛素-蛋白酶体途径调节许多核激素受体的周转,如雌激素受体。对于雌激素受体,蛋白酶体抑制会降低配体介导的转录。我们提供的证据表明,盐皮质激素受体(MR)以配体依赖的方式被泛素-蛋白酶体途径降解,并且蛋白酶体抑制导致MR积累增加,同时增强对醛固酮的转录反应。对人和大鼠MR一级序列的研究确定了两个候选的PEST降解基序。该PEST元件内赖氨酸715和/或367的突变未能阻止MR蛋白的降解或醛固酮介导的转录活性,表明其他赖氨酸残基是MR蛋白酶体降解的靶点。这些发现证明了MR上调与转录活性增强之间的联系。